-
Forward Look
Adequate RepresentationMedical oncologist Lola Fashoyin-Aje describes the Food and Drug Administration’s efforts to make clinical trials more inclusive.
by Erin O'Donnell
-
Forward Look
Comparing Antibody-Drug Conjugates for Metastatic Breast CancerResults favor Enhertu for treating metastatic breast cancer that recurs or does not respond to first-line treatment.
by Kris Conner
-
Forward Look
Who Benefits From Immunotherapy?Success of immune checkpoint inhibitors in clinical trials does not always carry over to patients in the clinic.
by Delia O'Hara
-
Forward Look
What’s Next?Artificial intelligence may help to classify colorectal polyps.
by Nancy Averett
-
Forward Look
Fasting-Mimicking Diet Increases Anti-Tumor ImmunityResearch suggests short bursts of intense calorie restriction could improve treatment response in patients with a range of cancers.
by Robin Donovan
-
Forward Look
Coordination of CarePilot program emphasizes standards to streamline patient care.
by Carolyn Bernhardt
-
How COVID-19 Changed Cancer CareA new report from the American Association for Cancer Research explores how the COVID-19 pandemic affected cancer patients, researchers and care providers.
by Eric Fitzsimmons
-
2021: The Year in Cancer NewsThe Cancer Today editorial staff selects some of the most impactful reporting and essays of 2021.
by Cancer Today Staff
-
From the Editor-in-Chief
Astronomy Meets PathologyData analysis platforms that map the cosmos are being applied to map the tumor microenvironment, an approach that could revolutionize cancer pathology.
by William G. Nelson, MD, PhD
-
Forward Look
CAR T Cells for Blood Cancer PatientsResearchers aim to minimize disease relapses by targeting multiple proteins.
by Erin O'Donnell
U.S. breast cancer deaths declined for women ages 20 to 49, which researchers credit to wider screening and better treatment.
by Kevin McLaughlin
Missed Activities Due to Cancer-related Fatigue and DepressionWomen were more likely than men to have fatigue or depression linked to cancer, and both effects were linked to people withdrawing from physical activities.
by Eric Fitzsimmons
Immunotherapy Improves Results in Head and Neck CancerCombining an immune checkpoint inhibitor with standard care extended event-free survival by nearly two years.
by Thomas Celona
Federal Support for Cancer Research Takes the Stage at AACR Annual MeetingScientists and former administrators gather for session focused on advocating for cancer research in uncertain times.
by Kevin McLaughlin
-
Inaugural AACR IO Conference Kicks Off With Celebration of Immune CheckpointsImmune checkpoint icons James Allison and Arlene Sharpe shared their journeys and a look ahead on the opening night of the inaugural AACR IO conference.
-
A New Resource Provides a Sanctuary for Black TNBC PatientsThe Black TNBC Sanctuary was created to help Black women with triple-negative breast cancer get answers about their diagnosis and care.
Dr. Humberto M. Guiot: Targeting Pancreatic Cancer in a Community-Based Clinical Trial
